Cigna Group Announces CEO Change
The Cigna Group has a succession plan in place. The company announced that President and COO Brian Evanko will succeed David Cordani as CEO on July 1, 2026. Cordani will transition to the role of Executive Chair of the Board.
David Cordani's tenure as CEO, which began in 2009, has been defined by transformative acquisitions. Most notably, he orchestrated the $67 billion purchase of pharmacy benefit manager Express Scripts in 2018, a move that significantly reshaped the company and the broader healthcare landscape. The leadership change follows a period of strategic realignment for Cigna. The company recently divested its Medicare Advantage and CareAllies businesses, selling them to Health Care Service Corporation (HCSC) in a deal valued at approximately $3.3 billion. This move came after Cigna abandoned talks of a mega-merger with competitor Humana in late 2024. Incoming CEO Brian Evanko is a Cigna veteran, having joined the company in 1998. An actuary by training, he has held numerous leadership positions, including Chief Financial Officer and, most recently, President and Chief Operating Officer, giving him deep financial and operational knowledge of the entire enterprise. Evanko's career has spanned both domestic and international operations, with leadership roles in Hong Kong and Singapore. Before becoming COO, he was the President and CEO of the Cigna Healthcare division, the company's health benefits portfolio, and also led the U.S. Government business, including its Medicare and Individual and Family Plans.
